Reported Oct 27, 2021 · Terminated
GlipiZIDE Extended-Release Tablets, 2.5 mg, 30 Tablets (3 blister cards each with 10 individually blistered doses), Rx…
American Health Packaging
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: American Health Packaging · 2550 John Glenn Ave Ste A · Columbus, OH · 43217-1188
Is this the product you have?
- GlipiZIDE Extended-Release Tablets, 2.5 mg, 30 Tablets (3 blister cards each with 10 individually blistered doses), Rx only
- Manufactured byPatheon Pharmaceuticals Inc., Cincinnati, OH 45237
- Distributed byActavis Pharma, Inc., Parsippany, NJ 07054. Carton NDC#: 68084-295-21 (Individual
- Dose NDC68084-295-11)
- Lot codes and dates
Lot #: 194141Exp. Date 03/31/2022
- Amount recalled
- 2,266 cartons
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specifications: results were above specification.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new American Health Packaging recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.